Evidence map›Paper›PMID 39121892›Full record

ArticleBiofabrication2024

Effect of viscosity of gelatin methacryloyl-based bioinks on bone cells.

Ahmad Rashad, Alejandro Gomez, Ankit Gangrade, Fatemeh Zehtabi, Kalpana Mandal, Surjendu Maity, Changyu Ma, Bingbing Li, Ali Khademhosseini, Natan Roberto de Barros

Abstract read
In one paragraph

Article in Biofabrication, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmad RashadTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0001-9809-8760
Alejandro GomezTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.
Ankit GangradeTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0002-9169-7450
Fatemeh ZehtabiTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.
Kalpana MandalTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.
Surjendu MaityTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0003-0190-248X
Changyu MaTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.
Bingbing LiTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0001-6140-4189
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0002-2692-1524
Natan Roberto de BarrosTerasaki Institute for Biomedical Innovation, Los Angeles, CA 91367, United States of America.ORCID 0000-0001-8689-4110

Funding

Drug eluting injectable biomaterials for next generation chemoembolizationR01CA257558 · NCI · MAYO CLINIC ARIZONA · PI KHADEMHOSSEINI, ALI, OKLU, RAHMI · 2021 to 2025
$3.2M
Healing enterocutaneous fistulas using bioengineered biomaterialsR01DK130566 · NIDDK · MAYO CLINIC ARIZONA · PI KHADEMHOSSEINI, ALI, OKLU, RAHMI · 2022 to 2025
$2.2M
NCI NIH HHS R01 CA257558NIDDK NIH HHS R01 DK130566
6 · The paper itself

Abstract

The viscosity of gelatin methacryloyl (GelMA)-based bioinks generates shear stresses throughout the printing process that can affect cell integrity, reduce cell viability, cause morphological changes, and alter cell functionality. This study systematically investigated the impact of the viscosity of GelMA-gelatin bioinks on osteoblast-like cells in 2D and 3D culture conditions. Three bioinks with low, medium, and high viscosity prepared by supplementing a 5% GelMA solution with different concentrations of gelatin were evaluated. Cell responses were studied in a 2D environment after printing and incubation in non-cross-linked bioinks that caused the gelatin and GelMA to dissolve and release cells for attachment to tissue culture plates. The increased viscosity of the bioinks significantly affected cell area and aspect ratio. Cells printed using the bioink with medium viscosity exhibited greater metabolic activity and proliferation rate than those printed using the high viscosity bioink and even the unprinted control cells. Additionally, cells printed using the bioink with high viscosity demonstrated notably elevated expression levels of alkaline phosphatase and bone morphogenetic protein-2 genes. In the 3D condition, the printed cell-laden hydrogels were photo-cross-linked prior to incubation. The medium viscosity bioink supported greater cell proliferation compared to the high viscosity bioink. However, there were no significant differences in the expression of osteogenic markers between the medium and high viscosity bioinks. Therefore, the choice between medium and high viscosity bioinks should be based on the desired outcomes and objectives of the bone tissue engineering application. Furthermore, the bioprinting procedure with the medium viscosity bioink was used as an automated technique for efficiently seeding cells onto 3D printed porous titanium scaffolds for bone tissue engineering purposes.

Indexed as

BioprintingGelatinInkMethacrylatesAnimalsBone and BonesCell LineCell ProliferationCell SurvivalHumansOsteoblastsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsViscosityGelatingelatin methacryloylMethacrylatescell proliferationgelatinhydrogelsosteoblastsosteogenic differentiationrheologyshear stress

Identifiers

PMID39121892
PMCPMC11491941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.